Filter Specialty
Submit To The Journals

Paisley Myers

Paisley Trantham Myers graduated with her PhD in Analytical Biochemistry from the University of Virginia in 2016. Her graduate work under Professor Donald F Hunt utilized cutting-edge mass spectrometry and enrichment technology to identify aberrantly phosphorylated tumor antigens presented by HLA class I molecules at the cell surface. Her contribution to the phospho-immunopeptidome discovery research led to the identification of hundreds of cancer-associated phosphopeptide tumor targets, which were then licensed to Agenus. She continues this work, in her current role as a Senior Scientist at Agenus, characterizing the aberrant phospholigandome associated with cancer development and progression. This discovery work is the foundation for Agenus’ PhosphoSynVax™ vaccine platform, which is designed to produce novel off-the-shelf therapeutics that educate the immune system to recognize and kill tumor cells, promoting lasting anti-tumor immunity and improved overall survival.

Authored Articles

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchONCOLOGY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.